Detalhe da pesquisa
1.
Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study.
Biol Pharm Bull;
47(2): 411-416, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38346748
2.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Breast Cancer Res Treat;
202(3): 473-483, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37688665
3.
Metastasis-directed therapy for oligometastases in breast cancer.
Jpn J Clin Oncol;
53(10): 893-898, 2023 Oct 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37424379
4.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci;
113(9): 3169-3179, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35754298
5.
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
Cancer Sci;
113(5): 1808-1820, 2022 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35201661
6.
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
BMC Cancer;
22(1): 36, 2022 Jan 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34983437
7.
Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients.
Acta Med Okayama;
76(6): 661-671, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36549768
8.
Prospective observational study estimating willingness-to-pay for breast cancer treatments through contingent valuation method in Japanese breast cancer patients (JCOG1709A).
Jpn J Clin Oncol;
51(3): 498-503, 2021 Mar 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33438717
9.
Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
Support Care Cancer;
29(1): 437-443, 2021 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32388615
10.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Acta Med Okayama;
75(3): 357-362, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34176940
11.
NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
Breast Cancer Res Treat;
182(2): 325-332, 2020 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32462261
12.
Current situation and challenges regarding biosimilars in Japan: an example of trastuzumab biosimilars for breast cancer.
Future Oncol;
15(12): 1353-1361, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30767568
13.
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.
Int J Clin Oncol;
24(3): 262-273, 2019 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30392115
14.
Predictive value of genetic analysis for pathological complete response to preoperative treatment in HER2 positive, HR negative early breast cancer (PASSION trial).
Jpn J Clin Oncol;
48(4): 388-391, 2018 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29506214
15.
A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study.
Jpn J Clin Oncol;
48(9): 855-859, 2018 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30020510
16.
Pembrolizumab plus chemotherapy in triple-negative breast cancer.
Lancet;
398(10294): 24, 2021 07 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34217392
17.
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol;
17(1): 90-8, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26617202
18.
Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.
Cancer Sci;
107(10): 1465-1470, 2016 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27452985
19.
Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer.
Jpn J Clin Oncol;
45(1): 12-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25332421
20.
Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204.
Jpn J Clin Oncol;
45(10): 983-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26246481